Literature DB >> 29962541

A Convenient Synthesis of L-α-Vinylglycine from L-Homoserine Lactone.

David B Berkowitz1, Marianne K Smith1.   

Abstract

A procedure for the synthesis of L-α-vinylglycine from L-homoserine lactone is described. The route developed is convenient (only one chromatography step is required) and efficient (72% yield; ≥95% optical yield over 4 steps). Key features include the use of acid-labile protecting groups for the amino (Boc) and carboxyl (diphenylmethyl ester) groups, and the use of the phenylselenolate equivalent derived from sodium borohydride and diphenyl diselenide for L-homoserine lactone cleavage.

Entities:  

Year:  1996        PMID: 29962541      PMCID: PMC6022833          DOI: 10.1055/s-1996-4177

Source DB:  PubMed          Journal:  Synthesis (Stuttg)        ISSN: 0039-7881            Impact factor:   3.157


  7 in total

1.  Mechanism of the irreversible inhibition of aspartate aminotransferase by the bacterial toxin L-2-amino-4-methoxy-trans-3-butenoic acid.

Authors:  R R Rando; N Relyea; L Cheng
Journal:  J Biol Chem       Date:  1976-06-10       Impact factor: 5.157

2.  Irreversible inhibition of aspartate aminotransferase by 2-amino-3-butenoic acid.

Authors:  R R Rando
Journal:  Biochemistry       Date:  1974-09-10       Impact factor: 3.162

3.  Synthesis of beta,gamma-unsaturated amino acids.

Authors:  J E Baldwin; S B Haber; C Hoskins; L I Kruse
Journal:  J Org Chem       Date:  1977-04-01       Impact factor: 4.354

4.  Synthesis and resolution of vinylglycine, a beta,gamma-unsaturated alpha-amino acid.

Authors:  P Friis; P Helboe; P O Larsen
Journal:  Acta Chem Scand B       Date:  1974

5.  Selective inhibition of alanine aminotransferase and aspartate aminotransferase in rat hepatocytes.

Authors:  N W Cornell; P F Zuurendonk; M J Kerich; C B Straight
Journal:  Biochem J       Date:  1984-06-15       Impact factor: 3.857

6.  Cysteinesulfinate metabolism. altered partitioning between transamination and decarboxylation following administration of beta-methyleneaspartate.

Authors:  O W Griffith
Journal:  J Biol Chem       Date:  1983-02-10       Impact factor: 5.157

7.  Inactivation of bacterial D-amino acid transaminases by the olefinic amino acid D-vinylglycine.

Authors:  T S Soper; J M Manning; P A Marcotte; C T Walsh
Journal:  J Biol Chem       Date:  1977-03-10       Impact factor: 5.157

  7 in total
  6 in total

1.  Stereocontrolled total syntheses of isodomoic acids G and H via a unified strategy.

Authors:  Scott E Denmark; Jack Hung-Chang Liu; Joseck M Muhuhi
Journal:  J Org Chem       Date:  2010-12-01       Impact factor: 4.354

2.  Human serine racemase structure/activity relationship studies provide mechanistic insight and point to position 84 as a hot spot for β-elimination function.

Authors:  David L Nelson; Greg A Applegate; Matthew L Beio; Danielle L Graham; David B Berkowitz
Journal:  J Biol Chem       Date:  2017-07-10       Impact factor: 5.157

3.  Engineering acyclic stereocontrol in the alkylation of vinylglycine-derived dianions: asymmetric synthesis of higher alpha-vinyl amino acids.

Authors:  D B Berkowitz; J M McFadden; M K Sloss
Journal:  J Org Chem       Date:  2000-05-19       Impact factor: 4.354

4.  Synthesis and Deployment of an Elusive Fluorovinyl Cation Equivalent: Access to Quaternary α-(1'-Fluoro)vinyl Amino Acids as Potential PLP Enzyme Inactivators.

Authors:  Christopher D McCune; Matthew L Beio; Jill M Sturdivant; Roberto de la Salud-Bea; Brendan M Darnell; David B Berkowitz
Journal:  J Am Chem Soc       Date:  2017-09-28       Impact factor: 15.419

5.  Following an ISES lead: the first examples of asymmetric Ni(0)-mediated allylic amination.

Authors:  David B Berkowitz; Gourhari Maiti
Journal:  Org Lett       Date:  2004-08-05       Impact factor: 6.005

6.  Use of Fluorinated Functionality in Enzyme Inhibitor Development: Mechanistic and Analytical Advantages.

Authors:  David B Berkowitz; Kannan R Karukurichi; Roberto de la Salud-Bea; David L Nelson; Christopher D McCune
Journal:  J Fluor Chem       Date:  2008-09       Impact factor: 2.050

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.